PHDS HEALTHCARE RESEARCH Co., Ltd.
Provide research and development evaluation for new drugs abroad
Release time:
2015-09-26
2015 was a fruitful year for the Star of Broadcasting. The company was invited multiple times by foreign R&D enterprises to participate in discussions on new biopharmaceutical technologies and evaluations of R&D prospects.
2015 was a year of harvest for BoShiZhiXing. The company was invited multiple times by foreign R&D enterprises to participate in discussions on biopharmaceutical technology and evaluations of R&D prospects, such as 'cellular immune anti-cancer drugs' and 'recombinant coagulation factors'. PHDS experts listened carefully to the project proposals and detailed introductions, and combined them with current international and Chinese regulations and policies to submit a targeted 'Project Analysis Report' to the R&D institutions. The client evaluation report stated, 'The viewpoints are clear, the analysis is thorough, the positioning is appropriate, and the regulations are comprehensive, providing strong assistance for guiding researchers in their future processes, how to go to market, and how to enter the Chinese market. It is an excellent and high-value guiding report.' The client expressed great satisfaction. Such cases are just a small reflection of many high-quality and efficient projects by PHDS this year, with foreign clients giving rave reviews. We should take this as motivation to become a globally outstanding CRO and truly become a bridge for communication in health initiatives between the East and West!
Keyword:
Relevant regulations and policies
Key points and judgment principles for the quality management of non-clinical research of drugs
In order to standardize the on-site inspection work of Good Laboratory Practice (GLP) for non-clinical drug research and improve inspection quality, the "Key Points and Determination Principles for the Inspection of Good Laboratory Practice in Non-Clinical Drug Research" has been formulated in accordance with relevant requirements such as the "Drug Administration Law of the People's Republic of China," "Good Laboratory Practice for Non-Clinical Drug Research," and "Management Measures for the Certification of Good Laboratory Practice for Non-Clinical Drug Research."
2024-11-22
Technical requirements for the latest declaration data electronic disc
In order to further improve the quality and efficiency of the preparation of electronic application materials for drug registration, and to standardize the management of electronic application materials, our center has updated the "Technical Requirements for Electronic Discs of Application Materials" and "Structure of Electronic Documents for Drug Registration Applications" published on December 2, 2022, based on feedback.
2024-11-22
In December 2023, PHDS HEALTHCARE RESEARCH Co., Ltd. was elected as the vice president unit of the China Food and Drug Enterprise Quality Safety Promotion Association, as well as the vice chairman of its subordinate digital professional committee (Certificate No.: Zhong Shi Yao An Cu Hui Zheng Zi 798). The election and award ceremony took place at the Three Gorges Hospital of Chongqing Medical University.
2024-11-22
On March 26-27, 2024, the China Wuxi Global Oral Forum and the China Food and Drug Promotion Association High-Quality Development Conference, guided by the Wuxi Municipal People's Government and the Wuxi Council for the Promotion of International Trade, and organized by the China Food and Drug Promotion Association and the Oral Health Committee of the China Food and Drug Promotion Association, will be grandly held at the Wuxi International Conference Center.
2024-11-22
What if you have more needs?
Leave your demand information online and we will reply to you in time!
Contact Information
Customer service hotline:
E-mail:customer@cnphds.com
Address: Building A, Ocean Express,66 Xia Guang Li, Dong San Huan North Road,Chaoyang district, Beijing, China
Mobile
Public Number
京公网安备11010502056452号